Report Overview

The Brazil Antibiotics market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Antibiotic is an antimicrobial substance, which combats bacterial infections and occasionally protozoan infections. In addition, they are used to cure several diseases such as strep throat, urinary tract infections, sinus infections, pneumonia, skin infections, ear infections, and others. There are numerous ways of classifying antibiotics, however, the most common classification is based on their chemical structures, spectrum of activity, and mode of action. Currently, the demand for beta lactam and beta lactamase inhibitors class of antibiotics is high among healthcare providers.



Market Drivers

The growth of the antibiotics market is increasing due to increased consumption of antibiotics in low & middle-income families, major investments in R&D activities by pharmaceutical companies, and rise in prevalence of infectious diseases. Developments in generic drugs and the expanding vulnerable aging population are also contributing to the overall growth of this market

However, development of antibiotic resistance and increase in drug approval costs are projected to impede the market growth.

Major Antibiotic Actions

Based on the spectrum of activity, the market is bifurcated into broad-spectrum antibiotic and narrow-spectrum antibiotic. The broad-spectrum antibiotic segment is projected to exhibit the highest growth during the forecast period. This is attributed to the fact that broad-spectrum antibiotics act against a wide range of diseases, which in turn helps to combat antimicrobial resistance.